Correlation Between Lion Biotechnologies and BARRATT DEVEL

Can any of the company-specific risk be diversified away by investing in both Lion Biotechnologies and BARRATT DEVEL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lion Biotechnologies and BARRATT DEVEL into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lion Biotechnologies and BARRATT DEVEL UNSPADR2, you can compare the effects of market volatilities on Lion Biotechnologies and BARRATT DEVEL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lion Biotechnologies with a short position of BARRATT DEVEL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lion Biotechnologies and BARRATT DEVEL.

Diversification Opportunities for Lion Biotechnologies and BARRATT DEVEL

0.09

Correlation Coefficient

Lion Biotechnologies  BARRATT DEVEL

Significant diversification

The 3 months correlation between Lion and BARRATT is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Lion Biotechnologies and BARRATT DEVEL UNSPADR2 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BARRATT DEVEL UNSPADR2 and Lion Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lion Biotechnologies are associated (or correlated) with BARRATT DEVEL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BARRATT DEVEL UNSPADR2 has no effect on the direction of Lion Biotechnologies i.e., Lion Biotechnologies and BARRATT DEVEL go up and down completely randomly.

Pair Corralation between Lion Biotechnologies and BARRATT DEVEL

Assuming the 90 days trading horizon Lion Biotechnologies is expected to under-perform the BARRATT DEVEL. In addition to that, Lion Biotechnologies is 2.32 times more volatile than BARRATT DEVEL UNSPADR2. It trades about -0.25 of its total potential returns per unit of risk. BARRATT DEVEL UNSPADR2 is currently generating about -0.02 per unit of volatility. If you would invest  940.00  in BARRATT DEVEL UNSPADR2 on December 30, 2024 and sell it today you would lose (35.00) from holding BARRATT DEVEL UNSPADR2 or give up 3.72% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Lion Biotechnologies  vs.  BARRATT DEVEL UNSPADR2

Lion Biotechnologies

Risk-Adjusted Performance

Very Weak

Over the last 90 days Lion Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

BARRATT DEVEL UNSPADR2

Risk-Adjusted Performance

Very Weak

Over the last 90 days BARRATT DEVEL UNSPADR2 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, BARRATT DEVEL is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Lion Biotechnologies and BARRATT DEVEL

The main advantage of trading using opposite Lion Biotechnologies and BARRATT DEVEL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lion Biotechnologies position performs unexpectedly, BARRATT DEVEL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BARRATT DEVEL will offset losses from the drop in BARRATT DEVEL's long position.

The idea behind Lion Biotechnologies and BARRATT DEVEL UNSPADR2 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.